Exacerbation risk and characterisation of the UK’s asthma population from infants to old age
BackgroundFew studies have examined the characteristics of a general asthma population; most have focused on more severe patients or severe exacerbations.MethodsThis population-based cohort study, from April 2007 to September 2015, used linked primary and secondary care electronic healthcare records...
Gespeichert in:
Veröffentlicht in: | Thorax 2018-04, Vol.73 (4), p.313-320 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 320 |
---|---|
container_issue | 4 |
container_start_page | 313 |
container_title | Thorax |
container_volume | 73 |
creator | Bloom, Chloe I Nissen, Francis Douglas, Ian J Smeeth, Liam Cullinan, Paul Quint, Jennifer K |
description | BackgroundFew studies have examined the characteristics of a general asthma population; most have focused on more severe patients or severe exacerbations.MethodsThis population-based cohort study, from April 2007 to September 2015, used linked primary and secondary care electronic healthcare records (Clinical Practice Research Datalink, Hospital Episode Statistics). Characteristics of four age cohorts, ‘Under 5s’, ‘5 to 17s’, ‘18 to 54s’, ‘55+’, were described. Exacerbation risk factors, including asthma severity (measured by the British Thoracic Society (BTS) stepwise approach), were assessed using Poisson regression.Results424 326 patients with current asthma were eligible (n, median follow-up: ‘Under 5s’=17 320, 1 year; ‘5 to 17s’=82 707, 3.3 years; ‘18 to 54s’=210 724, 4 years; ‘55+’=113 575, 5.1 years). Over 60% of the total study population had mild asthma (BTS steps 1/2). There were differences between the cohort’s characteristics, including by gender, disease severity and exacerbation pattern. The rate of exacerbations was highest in the oldest cohort and lowest in the ‘5 to 17s’ cohort (rate per 10 person-years (95% CI), ‘Under 5s’=4.27 (4.18 to 4.38), ‘5 to 17s’=1.48 (1.47 to 1.50), ‘18 to 54s’=3.22 (3.21 to 3.24), ‘55+’=9.40 (9.37 to 9.42)). In all cohorts, exacerbation rates increased with increasing asthma severity, after adjusting for confounders including gender, socioeconomic status, smoking, body mass index, atopy, rhinitis, gastro-oesophageal reflux, anxiety, depression and COPD.ConclusionThe majority of UK patients with asthma had mild asthma and did not experience an exacerbation during follow-up. Patients aged ≥55 years had the lowest proportion with mild asthma and highest rate of exacerbations; the opposite was found in patients aged between 5 and 18 years. |
doi_str_mv | 10.1136/thoraxjnl-2017-210650 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1957460976</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2020443565</sourcerecordid><originalsourceid>FETCH-LOGICAL-b425t-f40bcf29d6cfe89f03b9c666af914ade604ac6bc3615eb45e772b0c0734129cc3</originalsourceid><addsrcrecordid>eNqNkcFO3DAURa0KVAboJxRZYsMm7bPj2OMlGgFFHakb2GLZjt1kSOLBdiS662_we3xJM8qUBStWT3r33KundxH6SuAbISX_npsQ9fNm6AoKRBSUAK_gE1oQxpdFSSU_QAsABgUvBT9CxyltAGBJiPiMjqgEwZaELdDD1bO2Lhqd2zDg2KZHrIca20ZHbbObFrMSPM6Nw_c_X_--JKxTbnqNt2E7drPuY-hxO3g95IRzwKGrsf7tTtGh111yX_bzBN1fX92tfhTrXze3q8t1YRitcuEZGOuprLn1bik9lEZazrn2kjBdOw5MW25syUnlDKucENSABVEyQqW15Qm6mHO3MTyNLmXVt8m6rtODC2NSRFaCcZCCT-j5O3QTxjhM1ykKFBgrK15NVDVTNoaUovNqG9texz-KgNoVoN4KULsC1FzA5Dvbp4-md_Wb6__HJwBmwPSbD2b-AyTklPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2020443565</pqid></control><display><type>article</type><title>Exacerbation risk and characterisation of the UK’s asthma population from infants to old age</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bloom, Chloe I ; Nissen, Francis ; Douglas, Ian J ; Smeeth, Liam ; Cullinan, Paul ; Quint, Jennifer K</creator><creatorcontrib>Bloom, Chloe I ; Nissen, Francis ; Douglas, Ian J ; Smeeth, Liam ; Cullinan, Paul ; Quint, Jennifer K</creatorcontrib><description>BackgroundFew studies have examined the characteristics of a general asthma population; most have focused on more severe patients or severe exacerbations.MethodsThis population-based cohort study, from April 2007 to September 2015, used linked primary and secondary care electronic healthcare records (Clinical Practice Research Datalink, Hospital Episode Statistics). Characteristics of four age cohorts, ‘Under 5s’, ‘5 to 17s’, ‘18 to 54s’, ‘55+’, were described. Exacerbation risk factors, including asthma severity (measured by the British Thoracic Society (BTS) stepwise approach), were assessed using Poisson regression.Results424 326 patients with current asthma were eligible (n, median follow-up: ‘Under 5s’=17 320, 1 year; ‘5 to 17s’=82 707, 3.3 years; ‘18 to 54s’=210 724, 4 years; ‘55+’=113 575, 5.1 years). Over 60% of the total study population had mild asthma (BTS steps 1/2). There were differences between the cohort’s characteristics, including by gender, disease severity and exacerbation pattern. The rate of exacerbations was highest in the oldest cohort and lowest in the ‘5 to 17s’ cohort (rate per 10 person-years (95% CI), ‘Under 5s’=4.27 (4.18 to 4.38), ‘5 to 17s’=1.48 (1.47 to 1.50), ‘18 to 54s’=3.22 (3.21 to 3.24), ‘55+’=9.40 (9.37 to 9.42)). In all cohorts, exacerbation rates increased with increasing asthma severity, after adjusting for confounders including gender, socioeconomic status, smoking, body mass index, atopy, rhinitis, gastro-oesophageal reflux, anxiety, depression and COPD.ConclusionThe majority of UK patients with asthma had mild asthma and did not experience an exacerbation during follow-up. Patients aged ≥55 years had the lowest proportion with mild asthma and highest rate of exacerbations; the opposite was found in patients aged between 5 and 18 years.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thoraxjnl-2017-210650</identifier><identifier>PMID: 29074814</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Adolescent ; Adult ; Age ; Aged ; Antibiotics ; Asthma ; Asthma - diagnosis ; Asthma - drug therapy ; Asthma - epidemiology ; Asthma - mortality ; Body Mass Index ; Child ; Child, Preschool ; Chronic obstructive pulmonary disease ; Clinical medicine ; Codes ; Cohort Studies ; Female ; Follow-Up Studies ; Gastroesophageal reflux ; Humans ; Infant ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Mortality ; Population ; Prevalence ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Smoking ; Studies ; United Kingdom - epidemiology</subject><ispartof>Thorax, 2018-04, Vol.73 (4), p.313-320</ispartof><rights>Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><rights>Copyright: 2018 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b425t-f40bcf29d6cfe89f03b9c666af914ade604ac6bc3615eb45e772b0c0734129cc3</citedby><cites>FETCH-LOGICAL-b425t-f40bcf29d6cfe89f03b9c666af914ade604ac6bc3615eb45e772b0c0734129cc3</cites><orcidid>0000-0003-0149-4869</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29074814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bloom, Chloe I</creatorcontrib><creatorcontrib>Nissen, Francis</creatorcontrib><creatorcontrib>Douglas, Ian J</creatorcontrib><creatorcontrib>Smeeth, Liam</creatorcontrib><creatorcontrib>Cullinan, Paul</creatorcontrib><creatorcontrib>Quint, Jennifer K</creatorcontrib><title>Exacerbation risk and characterisation of the UK’s asthma population from infants to old age</title><title>Thorax</title><addtitle>Thorax</addtitle><description>BackgroundFew studies have examined the characteristics of a general asthma population; most have focused on more severe patients or severe exacerbations.MethodsThis population-based cohort study, from April 2007 to September 2015, used linked primary and secondary care electronic healthcare records (Clinical Practice Research Datalink, Hospital Episode Statistics). Characteristics of four age cohorts, ‘Under 5s’, ‘5 to 17s’, ‘18 to 54s’, ‘55+’, were described. Exacerbation risk factors, including asthma severity (measured by the British Thoracic Society (BTS) stepwise approach), were assessed using Poisson regression.Results424 326 patients with current asthma were eligible (n, median follow-up: ‘Under 5s’=17 320, 1 year; ‘5 to 17s’=82 707, 3.3 years; ‘18 to 54s’=210 724, 4 years; ‘55+’=113 575, 5.1 years). Over 60% of the total study population had mild asthma (BTS steps 1/2). There were differences between the cohort’s characteristics, including by gender, disease severity and exacerbation pattern. The rate of exacerbations was highest in the oldest cohort and lowest in the ‘5 to 17s’ cohort (rate per 10 person-years (95% CI), ‘Under 5s’=4.27 (4.18 to 4.38), ‘5 to 17s’=1.48 (1.47 to 1.50), ‘18 to 54s’=3.22 (3.21 to 3.24), ‘55+’=9.40 (9.37 to 9.42)). In all cohorts, exacerbation rates increased with increasing asthma severity, after adjusting for confounders including gender, socioeconomic status, smoking, body mass index, atopy, rhinitis, gastro-oesophageal reflux, anxiety, depression and COPD.ConclusionThe majority of UK patients with asthma had mild asthma and did not experience an exacerbation during follow-up. Patients aged ≥55 years had the lowest proportion with mild asthma and highest rate of exacerbations; the opposite was found in patients aged between 5 and 18 years.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Antibiotics</subject><subject>Asthma</subject><subject>Asthma - diagnosis</subject><subject>Asthma - drug therapy</subject><subject>Asthma - epidemiology</subject><subject>Asthma - mortality</subject><subject>Body Mass Index</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Clinical medicine</subject><subject>Codes</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastroesophageal reflux</subject><subject>Humans</subject><subject>Infant</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Population</subject><subject>Prevalence</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Smoking</subject><subject>Studies</subject><subject>United Kingdom - epidemiology</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkcFO3DAURa0KVAboJxRZYsMm7bPj2OMlGgFFHakb2GLZjt1kSOLBdiS662_we3xJM8qUBStWT3r33KundxH6SuAbISX_npsQ9fNm6AoKRBSUAK_gE1oQxpdFSSU_QAsABgUvBT9CxyltAGBJiPiMjqgEwZaELdDD1bO2Lhqd2zDg2KZHrIca20ZHbbObFrMSPM6Nw_c_X_--JKxTbnqNt2E7drPuY-hxO3g95IRzwKGrsf7tTtGh111yX_bzBN1fX92tfhTrXze3q8t1YRitcuEZGOuprLn1bik9lEZazrn2kjBdOw5MW25syUnlDKucENSABVEyQqW15Qm6mHO3MTyNLmXVt8m6rtODC2NSRFaCcZCCT-j5O3QTxjhM1ykKFBgrK15NVDVTNoaUovNqG9texz-KgNoVoN4KULsC1FzA5Dvbp4-md_Wb6__HJwBmwPSbD2b-AyTklPA</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Bloom, Chloe I</creator><creator>Nissen, Francis</creator><creator>Douglas, Ian J</creator><creator>Smeeth, Liam</creator><creator>Cullinan, Paul</creator><creator>Quint, Jennifer K</creator><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0149-4869</orcidid></search><sort><creationdate>201804</creationdate><title>Exacerbation risk and characterisation of the UK’s asthma population from infants to old age</title><author>Bloom, Chloe I ; Nissen, Francis ; Douglas, Ian J ; Smeeth, Liam ; Cullinan, Paul ; Quint, Jennifer K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b425t-f40bcf29d6cfe89f03b9c666af914ade604ac6bc3615eb45e772b0c0734129cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Antibiotics</topic><topic>Asthma</topic><topic>Asthma - diagnosis</topic><topic>Asthma - drug therapy</topic><topic>Asthma - epidemiology</topic><topic>Asthma - mortality</topic><topic>Body Mass Index</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Clinical medicine</topic><topic>Codes</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastroesophageal reflux</topic><topic>Humans</topic><topic>Infant</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Population</topic><topic>Prevalence</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Smoking</topic><topic>Studies</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bloom, Chloe I</creatorcontrib><creatorcontrib>Nissen, Francis</creatorcontrib><creatorcontrib>Douglas, Ian J</creatorcontrib><creatorcontrib>Smeeth, Liam</creatorcontrib><creatorcontrib>Cullinan, Paul</creatorcontrib><creatorcontrib>Quint, Jennifer K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bloom, Chloe I</au><au>Nissen, Francis</au><au>Douglas, Ian J</au><au>Smeeth, Liam</au><au>Cullinan, Paul</au><au>Quint, Jennifer K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exacerbation risk and characterisation of the UK’s asthma population from infants to old age</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2018-04</date><risdate>2018</risdate><volume>73</volume><issue>4</issue><spage>313</spage><epage>320</epage><pages>313-320</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><abstract>BackgroundFew studies have examined the characteristics of a general asthma population; most have focused on more severe patients or severe exacerbations.MethodsThis population-based cohort study, from April 2007 to September 2015, used linked primary and secondary care electronic healthcare records (Clinical Practice Research Datalink, Hospital Episode Statistics). Characteristics of four age cohorts, ‘Under 5s’, ‘5 to 17s’, ‘18 to 54s’, ‘55+’, were described. Exacerbation risk factors, including asthma severity (measured by the British Thoracic Society (BTS) stepwise approach), were assessed using Poisson regression.Results424 326 patients with current asthma were eligible (n, median follow-up: ‘Under 5s’=17 320, 1 year; ‘5 to 17s’=82 707, 3.3 years; ‘18 to 54s’=210 724, 4 years; ‘55+’=113 575, 5.1 years). Over 60% of the total study population had mild asthma (BTS steps 1/2). There were differences between the cohort’s characteristics, including by gender, disease severity and exacerbation pattern. The rate of exacerbations was highest in the oldest cohort and lowest in the ‘5 to 17s’ cohort (rate per 10 person-years (95% CI), ‘Under 5s’=4.27 (4.18 to 4.38), ‘5 to 17s’=1.48 (1.47 to 1.50), ‘18 to 54s’=3.22 (3.21 to 3.24), ‘55+’=9.40 (9.37 to 9.42)). In all cohorts, exacerbation rates increased with increasing asthma severity, after adjusting for confounders including gender, socioeconomic status, smoking, body mass index, atopy, rhinitis, gastro-oesophageal reflux, anxiety, depression and COPD.ConclusionThe majority of UK patients with asthma had mild asthma and did not experience an exacerbation during follow-up. Patients aged ≥55 years had the lowest proportion with mild asthma and highest rate of exacerbations; the opposite was found in patients aged between 5 and 18 years.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>29074814</pmid><doi>10.1136/thoraxjnl-2017-210650</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-0149-4869</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0040-6376 |
ispartof | Thorax, 2018-04, Vol.73 (4), p.313-320 |
issn | 0040-6376 1468-3296 |
language | eng |
recordid | cdi_proquest_miscellaneous_1957460976 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adolescent Adult Age Aged Antibiotics Asthma Asthma - diagnosis Asthma - drug therapy Asthma - epidemiology Asthma - mortality Body Mass Index Child Child, Preschool Chronic obstructive pulmonary disease Clinical medicine Codes Cohort Studies Female Follow-Up Studies Gastroesophageal reflux Humans Infant Kaplan-Meier Estimate Male Middle Aged Mortality Population Prevalence Retrospective Studies Risk Factors Severity of Illness Index Smoking Studies United Kingdom - epidemiology |
title | Exacerbation risk and characterisation of the UK’s asthma population from infants to old age |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T04%3A10%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exacerbation%20risk%20and%20characterisation%20of%20the%20UK%E2%80%99s%20asthma%20population%20from%20infants%20to%20old%20age&rft.jtitle=Thorax&rft.au=Bloom,%20Chloe%20I&rft.date=2018-04&rft.volume=73&rft.issue=4&rft.spage=313&rft.epage=320&rft.pages=313-320&rft.issn=0040-6376&rft.eissn=1468-3296&rft_id=info:doi/10.1136/thoraxjnl-2017-210650&rft_dat=%3Cproquest_cross%3E2020443565%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2020443565&rft_id=info:pmid/29074814&rfr_iscdi=true |